Abstract

Study design – Prospective observational single-centre.
Purpose – To assess outcome of secondary IOL.
Methods – Patients with secondary IOL implantation from January 2023 were evaluated for visual acuity(VA), intraocular pressur(IOP), anterior chamber(AC) reaction and central macular thickness(CMT).
Results – Out of 46 patients, scleral fixated intraocular lens (SFIOL) was implanted in 65.2% by XNIT, retropupillary iris claw lens (RICL) in 26.1% and CMT-Flex in 8.7%. Mean age was 54.4±13.3 years and 71.7% were male. In 60% SFIOL and 33% RICL (p=0.12) patients, etiology was trauma. Mean VA (logMAR) improved from 2.04±0.32 to 0.65±0.38 at 6 months (p<0.01) with higher VA in those with RICL (p=0.04). Though AC flare was greater with SFIOL at day 7 (p=0.06), there was no difference at follow-up. Mean IOP was lower with RICL at 6 months (p=0.04). CMT was higher in SFIOL than RICL (330±140 vs 292±33.1) group at 6 months.
Conclusion – RICL was associated with better VA , lower CMT and IOP.